CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab
Conditions
- Cancer
- Non Small Cell Lung Cancer Metastatic
- Metastatic Melanoma
- Neoplasm of Lung
- Melanoma
Interventions
- DRUG: APX005M
- DRUG: Nivolumab
Sponsor
Apexigen America, Inc.
Collaborators